These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16079382)

  • 1. Histone deacetylase activity and COPD.
    Lin AY
    N Engl J Med; 2005 Aug; 353(5):528-9; author reply 528-9. PubMed ID: 16079382
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells.
    Kim B; Rincón Castro LM; Jawed S; Niles LP
    Eur J Pharmacol; 2008 Jul; 589(1-3):45-8. PubMed ID: 18550052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase activity and COPD.
    Bhowmik A
    N Engl J Med; 2005 Aug; 353(5):528-9; author reply 528-9. PubMed ID: 16080251
    [No Abstract]   [Full Text] [Related]  

  • 4. Decreased histone deacetylase activity in chronic obstructive pulmonary disease.
    Ito K; Ito M; Elliott WM; Cosio B; Caramori G; Kon OM; Barczyk A; Hayashi S; Adcock IM; Hogg JC; Barnes PJ
    N Engl J Med; 2005 May; 352(19):1967-76. PubMed ID: 15888697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COPD unwound.
    Shapiro SD
    N Engl J Med; 2005 May; 352(19):2016-9. PubMed ID: 15888704
    [No Abstract]   [Full Text] [Related]  

  • 6. Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation.
    Brunmeir R; Lagger S; Seiser C
    Int J Dev Biol; 2009; 53(2-3):275-89. PubMed ID: 19412887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC2 deficiency and histone acetylation.
    Ree AH; Folkvord S; Flatmark K
    Nat Genet; 2008 Jul; 40(7):812-3; author reply 813. PubMed ID: 18583969
    [No Abstract]   [Full Text] [Related]  

  • 8. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
    Thelen P; Schweyer S; Hemmerlein B; Wuttke W; Seseke F; Ringert RH
    Int J Oncol; 2004 Jan; 24(1):25-31. PubMed ID: 14654937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition.
    Ropero S; Fraga MF; Ballestar E; Hamelin R; Yamamoto H; Boix-Chornet M; Caballero R; Alaminos M; Setien F; Paz MF; Herranz M; Palacios J; Arango D; Orntoft TF; Aaltonen LA; Schwartz S; Esteller M
    Nat Genet; 2006 May; 38(5):566-9. PubMed ID: 16642021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative and positive regulation of gene expression by mouse histone deacetylase 1.
    Zupkovitz G; Tischler J; Posch M; Sadzak I; Ramsauer K; Egger G; Grausenburger R; Schweifer N; Chiocca S; Decker T; Seiser C
    Mol Cell Biol; 2006 Nov; 26(21):7913-28. PubMed ID: 16940178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylases 1 and 2 are expressed at distinct stages of neuro-glial development.
    MacDonald JL; Roskams AJ
    Dev Dyn; 2008 Aug; 237(8):2256-67. PubMed ID: 18651664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of airway inflammation.
    Adcock IM; Tsaprouni L; Bhavsar P; Ito K
    Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1.
    Huang BH; Laban M; Leung CH; Lee L; Lee CK; Salto-Tellez M; Raju GC; Hooi SC
    Cell Death Differ; 2005 Apr; 12(4):395-404. PubMed ID: 15665816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells.
    Dejligbjerg M; Grauslund M; Litman T; Collins L; Qian X; Jeffers M; Lichenstein H; Jensen PB; Sehested M
    Mol Cancer; 2008 Sep; 7():70. PubMed ID: 18789133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroids: the drugs to beat.
    Barnes PJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):2-14. PubMed ID: 16436275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration.
    Ito K; Hanazawa T; Tomita K; Barnes PJ; Adcock IM
    Biochem Biophys Res Commun; 2004 Feb; 315(1):240-5. PubMed ID: 15013452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2.
    Osoata GO; Yamamura S; Ito M; Vuppusetty C; Adcock IM; Barnes PJ; Ito K
    Biochem Biophys Res Commun; 2009 Jul; 384(3):366-71. PubMed ID: 19410558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the pharmacokinetic properties of phosphorus-containing selective HDAC 1 and 2 inhibitors (SHI-1:2).
    Heidebrecht RW; Chenard M; Close J; Dahlberg WK; Fleming J; Grimm JB; Hamill JE; Harsch A; Haines BB; Hughes B; Kral AM; Middleton RE; Mushti C; Ozerova N; Szewczak AA; Wang H; Wilson K; Witter DJ; Secrist JP; Miller TA
    Bioorg Med Chem Lett; 2009 Apr; 19(7):2053-8. PubMed ID: 19268585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
    Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC
    Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone modifier, the gatekeeper of good memory.
    Qiu Z
    Cell Res; 2009 Aug; 19(8):920-1. PubMed ID: 19648947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.